Author:
Wang Bo,Jiang Yufeng,Wang Zhuo,Li Fangfang,Xing Guoqiang,Peng Xinyu,Zhang Shijie,Lv Hailong
Abstract
ABSTRACTSpillage of cyst contents during surgery is the major cause of recurrences of hydatidosis, also called cystic echinococcosis (CE). Currently, many scolicidal agents are used for inactivation of the cyst contents. However, due to complications in the use of those agents, new and more-effective treatment options are urgently needed. The aim of this study was to investigate thein vitroefficacy of arsenic trioxide (ATO) againstEchinococcus granulosusprotoscolices. Protoscolices ofE. granulosuswere incubatedin vitrowith 2, 4, 6, and 8 μmol/liter ATO; viability of protoscolices was assessed daily by microscopic observation of movements and 0.1% eosin staining. A small sample from each culture was processed for scanning and transmission electron microscopy. ATO demonstrated a potent ability to kill protoscolices, suggesting that ATO may represent a new strategy in treating hydatid cyst echinococcosis. However, thein vivoefficacy and possible side effects of ATO need to be explored.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference31 articles.
1. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway;Pharmazie,2013
2. In vitro and in vivo treatments of Echinococcus granulosus with Huaier aqueous extract and albendazole liposome;Parasitol Res,2013
3. Efficacy of chlorhexidine gluconate during surgery for hydatid cyst;World J Surg,2009
4. Echinococcosis: a review;Int J Infect Dis,2009
5. In vitro effectiveness of acidic and alkline solutions on scolices of hydatid cyst;Parasitol Res,2010
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献